IRRC Corporation (7325.T)
Tokyo, JP
Headquartered in Tokyo, Japan, IRRC Corporation operates as a prominent life insurance agency within the country. The company not only distributes its products through proprietary retail locations but also provides non-life insurance brokerage and essential sales support services to the broader insurance sector. Furthermore, IRRC develops and supplies sophisticated technological tools designed for the insurance industry. These include Smart OCR for electronic document management, the Hoken IQ System for insurance analysis and search, AS-BOX for streamlining insurance applications, and the AS System, which aids financial institutions and various insurance agencies in analyzing life insurance scenarios and formulating proposals. The corporation has been in operation since its founding in 1995.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.64% | -8.98% | -8.55% | -11.82% | -9.70% | -5.83% | +8.95% | +9.71% | -29.94% | -21.33% | -21.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-12 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%+19.0% ★ Q1'26: +22.2% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%+24.3% ★ Q1'26: -14.7% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+10.3% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+7.9% Q1'26: +7.5% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+28.0% ★ Q1'26: +18.4% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%-1.1% ★ Q1'26: -1.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×0.01× ★ Q1'26: 0.42× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. 1 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
Jun 2029 1 Rev. Ana. 1 EPS Ana. |
Jun 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.82B
est.
|
4.17B
est: 4.11B (+1.3%)
|
4.63B
est: 4.50B (+2.9%)
|
5.20B
est: 5.20B (0.0%)
|
6.00B
est: 5.90B (+1.8%)
|
7.92B
est: 7.90B (+0.3%)
|
9.42B
est: 9.30B (+1.3%)
|
11.30B
11.30B – 11.30B
+21.5% YoY
|
13.00B
13.00B – 13.00B
+15.0% YoY
|
15.20B
15.20B – 15.20B
+16.9% YoY
|
17.40B
17.40B – 17.40B
+14.5% YoY
|
19.60B
19.60B – 19.60B
+12.6% YoY
|
| EBITDA |
401.80M
est.
|
658.72M
est: 433.06M (+52.1%)
|
572.17M
est: 473.70M (+20.8%)
|
640.75M
est: 547.38M (+17.1%)
|
381.35M
est: 621.07M (-38.6%)
|
795.49M
est: 831.60M (-4.3%)
|
1.09B
est: 978.98M (+11.3%)
|
1.19B
1.19B – 1.19B
+21.5% YoY
|
1.37B
1.37B – 1.37B
+15.0% YoY
|
1.60B
1.60B – 1.60B
+16.9% YoY
|
1.83B
1.83B – 1.83B
+14.5% YoY
|
2.06B
2.06B – 2.06B
+12.6% YoY
|
| EBIT |
241.98M
est.
|
485.01M
est: 260.81M (+86.0%)
|
366.00M
est: 285.28M (+28.3%)
|
403.48M
est: 329.65M (+22.4%)
|
115.00M
est: 374.03M (-69.3%)
|
495.00M
est: 500.82M (-1.2%)
|
741.62M
est: 589.57M (+25.8%)
|
716.36M
716.36M – 716.36M
+21.5% YoY
|
824.13M
824.13M – 824.13M
+15.0% YoY
|
963.60M
963.60M – 963.60M
+16.9% YoY
|
1.10B
1.10B – 1.10B
+14.5% YoY
|
1.24B
1.24B – 1.24B
+12.6% YoY
|
| Net Income |
318.74M
est.
|
323.21M
est: 284.32M (+13.7%)
|
233.32M
est: 249.91M (-6.6%)
|
255.98M
est: 288.42M (-11.2%)
|
16.04M
est: 94.23M (-83.0%)
|
351.62M
est: 217.13M (+61.9%)
|
435.45M
est: 419.52M (+3.8%)
|
510.47M
510.47M – 510.47M
+21.7% YoY
|
771.85M
771.85M – 771.85M
+51.2% YoY
|
1.05B
1.05B – 1.05B
+36.3% YoY
|
1.33B
1.33B – 1.33B
+26.6% YoY
|
1.61B
1.61B – 1.61B
+21.1% YoY
|
| SGA |
1.68B
est.
|
3.12B
est: 1.81B (+72.5%)
|
3.57B
est: 1.98B (+80.3%)
|
—
est: 2.28B (-100.0%)
|
—
est: 2.59B (-100.0%)
|
5.74B
est: 3.47B (+65.3%)
|
6.63B
est: 4.09B (+62.2%)
|
4.96B
4.96B – 4.96B
+21.5% YoY
|
5.71B
5.71B – 5.71B
+15.0% YoY
|
6.68B
6.68B – 6.68B
+16.9% YoY
|
7.65B
7.65B – 7.65B
+14.5% YoY
|
8.61B
8.61B – 8.61B
+12.6% YoY
|
| EPS |
38.90
est.
|
37.86
est: 34.70 (+9.1%)
|
27.33
est: 30.50 (-10.4%)
|
29.94
est: 35.20 (-14.9%)
|
1.85
est: 11.50 (-83.9%)
|
42.36
est: 26.50 (+59.8%)
|
53.14
est: 51.20 (+3.8%)
|
62.30
62.30 – 62.30
+21.7% YoY
|
94.20
94.20 – 94.20
+51.2% YoY
|
128.40
128.40 – 128.40
+36.3% YoY
|
162.60
162.60 – 162.60
+26.6% YoY
|
196.90
196.90 – 196.90
+21.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Katsuhiro Hanzawa | CCO, Vice President, GM of Sales Headquarters & Director | — | male |
| Kenjiro Takebe | Vice President, GM of Management Office & Solutions Business Division and Director | — | — |
| Naoaki Aihara | Chief Financial Officer, GM of Management Headquarters & Director | — | male |
| Nobuhiro Katsumoto | Chief Technology Officer, Head of System Headquarters & Director | — | male |
| Ryuji Katsumoto | Chief Executive Officer, President & Representative Director | — | male |
| Yasuhiro Kii | Chief Operating Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7325.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
